Abstract
This paper was aimed to explore the application of the block matching pyramid (BMP) algorithm in echocardiographic spot tracking in patients with coronary heart disease (CHD) and angina pectoris, as well as the effect of Shexiang Baoxin pills (a kind of drug containing musk, which is good for cardiac diseases) on blood lipids, cardiac function, and curative effect. 206 patients with CHD angina pectoris in the hospital from July 2018 to May 2020 were selected as the research subjects and were enrolled into the control (Ctrl) group (conventional treatment, n = 103) and the observation group (the Shexiang Baoxin pill was given on the basis of conventional treatment, n = 103) in random. Then, the patients' echocardiograms were obtained, and the BMP algorithm was used to track the echocardiograms. At 12 months after treatment, the total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were compared. Besides, the differences between left ventricular end-systolic volume (LVESV), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic dimension (LVEDD), cardiac index (CI), cardiac output (CO), and LVEF were observed. Finally, the efficacy of angina pectoris and electrocardiogram was calculated. It was found that the BMP algorithm can track the echocardiograms and display the movement and displacement of the patients' left ventricle. After treatment, in contrast with the Ctrl, the levels of TC, TG, and LDL-C in the observation group were obviously lower (P < 0.05); the LVESV, LVEDV, and LVEF were obviously lower (P < 0.05), the LVESD, LVEDD, CO, and CI were obviously higher (P < 0.05), the total score of angina after treatment was obviously lower (P < 0.05), and the total effective rates of angina pectoris and echocardiogram were obviously higher (P < 0.05). In conclusion, echocardiographic spot tracking can realize the diagnosis of patients with CHD angina pectoris, and Shexiang Baoxin pill can regulate the blood lipid level and improve the echocardiographic indicators and the clinical efficacy is obvious.
Highlights
In recent years, the incidence and mortality of coronary heart disease (CHD) in China have shown an upward trend year by year, which has seriously threatened people’s lives and health
Surgical treatment can realize the recanalization of the occluded blood vessels, improve the symptoms, and reduce cardiovascular events such as myocardial infarction [1, 2]. e occurrence of CHD angina is correlated with the increase of blood lipid levels and vascular endothelial injury [3]. erefore, the clinical treatment of CHD needs to relieve the symptoms of patients with angina and needs to control blood lipids and other risk factors for cardiovascular diseases
Traditional Chinese medicine (TCM) has a long history of treating CHD angina pectoris, and studies have confirmed that TCM is better than Western medicine in treating CHD angina
Summary
The incidence and mortality of CHD in China have shown an upward trend year by year, which has seriously threatened people’s lives and health. The methods commonly used in clinical treatment of CHD are percutaneous coronary intervention or coronary artery bypass surgery. Surgical treatment can realize the recanalization of the occluded blood vessels, improve the symptoms, and reduce cardiovascular events such as myocardial infarction [1, 2]. E occurrence of CHD angina is correlated with the increase of blood lipid levels and vascular endothelial injury [3]. Erefore, the clinical treatment of CHD needs to relieve the symptoms of patients with angina and needs to control blood lipids and other risk factors for cardiovascular diseases. Shexiang Baoxin pill is a TCM preparation, which is developed for clinical treatment of cardiovascular diseases. Studies have proved that Shexiang Baoxin pills can improve patients’ ECG performance and reduce the incidence of cardiovascular events [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
